unknown
Stage
About
Ambros Therapeutics is a clinical-stage biotechnology company developing neridronate, a bisphosphonate drug candidate, to treat Complex Regional Pain Syndrome Type 1 (CRPS-1), a rare and debilitating pain condition.
Explore Ambros Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.